New Treatment Methods for Waste Water Containing Chloride Ion Using Magnesium–Aluminum Oxide

2000 ◽  
Vol 29 (10) ◽  
pp. 1136-1137 ◽  
Author(s):  
Tomohito Kameda ◽  
Yoshinori Miyano ◽  
Toshiaki Yoshioka ◽  
Miho Uchida ◽  
Akitsugu Okuwaki
Keyword(s):  
Waste Water ◽  
Aluminum Oxide ◽  
Chloride Ion ◽  
Treatment Methods ◽  
New Treatment ◽  
Magnesium Aluminum Oxide

New Treatment Method for Dilute Hydrochloric Acid Using Magnesium-Aluminum Oxide

2002 ◽  
Vol 75 (3) ◽  
pp. 595-599 ◽  
Author(s):  
Tomohito Kameda ◽  
Toshiaki Yoshioka ◽  
Miho Uchida ◽  
Yoshinori Miyano ◽  
Akitsugu Okuwaki
Keyword(s):  
Hydrochloric Acid ◽  
Aluminum Oxide ◽  
Dilute Hydrochloric Acid ◽  
Treatment Method ◽  
New Treatment ◽  
Magnesium Aluminum Oxide

The removal of chloride from solutions with various cations using magnesium–aluminum oxide

2005 ◽  
Vol 42 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Tomohito Kameda ◽  
Toshiaki Yoshioka ◽  
Tatsunosuke Hoshi ◽  
Miho Uchida ◽  
Akitsugu Okuwaki
Keyword(s):  
Aluminum Oxide ◽  
Magnesium Aluminum Oxide

scholarly journals Waste Water Treatment Methods

10.5772/53755 ◽  
2013 ◽  
Author(s):  
Adina Elena ◽  
Cristina Orbeci ◽  
Carmen Lazau ◽  
Paula Sfirloaga ◽  
Paulina Vlazan ◽  
...  
Keyword(s):  
Waste Water ◽  
Water Treatment ◽  
Waste Water Treatment ◽  
Treatment Methods

scholarly journals New Treatment Options for Chronic Constipation: Mechanisms, Efficacy and Safety

2011 ◽  
Vol 25 (suppl b) ◽  
pp. 29B-35B ◽  
Author(s):  
Michael Camilleri
Keyword(s):  
Bile Acid ◽  
Serotonin Receptor ◽  
Treatment Options ◽  
Chloride Ion ◽  
New Drugs ◽  
Receptor Subtype ◽  
Efficacy And Safety ◽  
Guanylate Cyclase C ◽  
Patient Responsiveness ◽  
New Treatment

The present review has several objectives, the first of which is to review the pharmacology and selectivity of serotonergic agents to contrast the older serotonergic agents (which were withdrawn because of cardiac or vascular adverse effects) with the newer generation serotonin receptor subtype 4 agonists. Second, the chloride ion secretagogues that act through the guanylate cyclase C receptor are appraised and their pharmacology is compared with the approved medication, lubiprostone. Third, the efficacy and safety of the application of bile acid modulation to treat constipation are addressed. The long-term studies of surgically induced excess bile acid delivery to the colon are reviewed to ascertain the safety of this therapeutic approach. Finally, the new drugs for opiate-induced constipation are introduced. Assuming these drugs are approved, practitioners will have a choice; however, patient responsiveness will be based on trial and error. Nevertheless, the spectrum of mechanisms and demonstrated efficacy and safety augur well for satisfactory treatment outcomes.

scholarly journals Surgical Treatment of Wounds Using Stem Cells in Epidermolysis Bullosa (EB)

2021 ◽  
Author(s):  
Magdalena Nita ◽  
Jacek Pliszczyński ◽  
Andrzej Eljaszewicz ◽  
Marcin Moniuszko ◽  
Tomasz Ołdak ◽  
...  
Keyword(s):  
Stem Cells ◽  
Epidermolysis Bullosa ◽  
Skin Diseases ◽  
Complex Structure ◽  
Mechanical Stimuli ◽  
Treatment Methods ◽  
New Treatment ◽  
Induced Pluripotent ◽  
The Many ◽  
Treatment Of Wounds

Epidermolysis bullosa (EB) is a group of hereditary skin diseases, or genodermatoses, characterized by the formation of severe, chronic blisters with painful and life-threatening complications. Despite the previous and ongoing progress in the field, there are still no effective causative treatments for EB. The treatment is limited to relieving symptoms, which—depending on disease severity—may involve skin (blisters, poorly healing wounds caused by the slightest mechanical stimuli, contractures, scarring, pseudosyndactyly) and internal organ abnormalities (esophageal, pyloric, or duodenal atresia; renal failure; and hematopoietic abnormalities). The last decade saw a series of important discoveries that paved the way for new treatment methods, including gene therapy, bone marrow transplantation, cell therapy (allogenic fibroblasts, mesenchymal stem cells [MSCs], and clinical use of induced pluripotent stem cells. Tissue engineering experts are attempting to develop skin-like structures that can facilitate the process of healing to promote skin reconstruction in injuries that are currently incurable. However, this is incredibly challenging, due to the complex structure and the many functions of the skin. Below, we characterize EB and present its potential treatment methods. Despite the cure for EB being still out of reach, recent data from animal models and initial clinical trials in humans have raised patients’, clinicians’, and researchers’ expectations. Consequently, modifying the course of the disease and improving the quality of life have become possible. Moreover, the conclusions drawn based on EB treatment may considerably improve the treatment of other genetic diseases.

scholarly journals OPTOGENETICS AND ITS INFLUENCE ON THE CLINICAL NEUROSCIENCES

2020 ◽  
Author(s):  
Mateusz Gotowiec
Keyword(s):  
Single Cell ◽  
Neural Activity ◽  
Neurodegenerative Disorders ◽  
Rapid Change ◽  
Cell Manipulation ◽  
Clinical Neuroscience ◽  
Treatment Methods ◽  
The Future ◽  
New Treatment ◽  
Single Cell Manipulation

Optogenetics, the control of neural activity using light, is a recent development in the field of clinical neuroscience and has brought significant reform to the domain. The “optogenetic revolution” has fueled the expansion of three main areas: the cell-specific understanding of neurodegenerative disorders, development of new treatment methods and evolution of biotechnological approaches. The possibility created by optogenetics of single-cell manipulation and the identification of specific neuronal pathways allows for a radically clearer grasp of the brain’s functioning. However, despite its promising outlook, the future of optogenetics remains unclear. Especially the transition from animal-based models to human application requires a significant advancement of the field, with technological and physiological obstacles that have so far proven unsurpassable. Thus, the question is posed whether the rapid change which optogenetics brought to clinical neurosciences will continue gaining momentum in the coming years.

Sign in / Sign up

Export Citation Format

Share Document